Retrospective evaluation of enoxaparin dosing in patients 48 weeks' postmenstrual age or younger in a neonatal intensive care unit.

Hicks, J Kevin; Shelton, Chasity M; Sahni, Jasmine K; Christensen, Michael L

Hicks, J Kevin; Shelton, Chasity M; Sahni, Jasmine K; Christensen, Michael L.

Affiliation

Hicks JK; Department of Pharmacy, Le Bonheur Children's Hospital, Memphis, TN, USA. Kevin.hicks@stjude.org

Ann Pharmacother ; 46(7-8): 943-51, 2012.

Article in En | MEDLINE | ID: mdl-22828970

Subject(s)

Anticoagulants/administration & dosage; Enoxaparin/administration & dosage; Factor Xa Inhibitors; Factor Xa/metabolism; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Enoxaparin / Factor Xa Inhibitors / Anticoagulants Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Newborn Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2012 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google